Literature DB >> 14572626

Basal norepinephrine in depersonalization disorder.

Daphne Simeon1, Orna Guralnik, Margaret Knutelska, Rachel Yehuda, James Schmeidler.   

Abstract

In contrast to the noradrenergic dysregulation described in PTSD, little is known regarding noradrenergic function in dissociative disorders. The purpose of this preliminary study was to investigate basal norepinephrine in depersonalization disorder (DPD). Nine subjects with DSM-IV DPD, without lifetime PTSD, were compared to nine healthy comparison (HC) subjects. Norepinephrine was measured via 24-h urine collection and three serial plasma determinations. Groups did not differ significantly in plasma norepinephrine levels. Compared to the HC group, the DPD group demonstrated significantly higher urinary norepinephrine, only prior to covarying for anxiety. The DPD group also demonstrated a highly significant inverse correlation between urinary norepinephrine and depersonalization severity (r=-0.88). Norepinephrine and cortisol levels (reported in a prior study) were not intercorrelated. We concluded that although dissociation accompanied by anxiety was associated with heightened noradrenergic tone, there was a marked basal norepinephrine decline with increasing severity of dissociation. The findings are in concordance with the few reports on autonomic blunting in dissociation and merit further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572626     DOI: 10.1016/s0165-1781(03)00205-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

Review 1.  Depersonalisation disorder: a contemporary overview.

Authors:  Daphne Simeon
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

2.  Magical flight and monstrous stress: technologies of absorption and mental wellness in Azeroth.

Authors:  Jeffrey G Snodgrass; Michael G Lacy; H J Francois Dengah; Jesse Fagan; David E Most
Journal:  Cult Med Psychiatry       Date:  2011-03

3.  STRESS AND TRAUMA: Psychotherapy and Pharmacotherapy for Depersonalization/Derealization Disorder.

Authors:  Julie P Gentile; Malynda Snyder; Paulette Marie Gillig
Journal:  Innov Clin Neurosci       Date:  2014-07

4.  Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers.

Authors:  Daphne Simeon; Margaret Knutelska; Rachel Yehuda; Frank Putnam; James Schmeidler; Lisa M Smith
Journal:  Biol Psychiatry       Date:  2006-11-29       Impact factor: 13.382

5.  Elevated salivary alpha amylase in adolescent sexual abuse survivors with posttraumatic stress disorder symptoms.

Authors:  Brooks R Keeshin; Jeffrey R Strawn; Dorothee Out; Douglas A Granger; Frank W Putnam
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-03-24       Impact factor: 2.576

Review 6.  Dissociation and borderline personality disorder: an update for clinicians.

Authors:  Marilyn I Korzekwa; Paul F Dell; Clare Pain
Journal:  Curr Psychiatry Rep       Date:  2009-02       Impact factor: 5.285

7.  Dissociative experience and cultural neuroscience: narrative, metaphor and mechanism.

Authors:  Rebecca Seligman; Laurence J Kirmayer
Journal:  Cult Med Psychiatry       Date:  2008-03

Review 8.  Respiratory therapy for the treatment of anxiety: Meta-analytic review and regression.

Authors:  Teresa M Leyro; Mark V Versella; Min-Jeong Yang; Hannah R Brinkman; Danielle L Hoyt; Paul Lehrer
Journal:  Clin Psychol Rev       Date:  2021-01-24

9.  Abnormal cardiovascular sympathetic and parasympathetic responses to physical and emotional stimuli in depersonalization disorder.

Authors:  Andrew P Owens; Anthony S David; David A Low; Christopher J Mathias; Mauricio Sierra-Siegert
Journal:  Front Neurosci       Date:  2015-03-26       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.